Business Description
Opthea Ltd
NAICS : 325412
SIC : 2834
ISIN : AU000000OPT2
Compare
Compare
Traded in other countries / regions
OPT.AustraliaOPT.USAUKJ.Germany IPO Date
2017-04-11Description
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1209.59 | |||||
| Equity-to-Asset | -0.28 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -7.08 | |||||
| Beneish M-Score | -3.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -68.8 | |||||
| 3-Year EPS without NRI Growth Rate | -99.3 | |||||
| 3-Year FCF Growth Rate | -133.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.66 | |||||
| 9-Day RSI | 39.65 | |||||
| 14-Day RSI | 42.51 | |||||
| 6-1 Month Momentum % | 167.08 | |||||
| 12-1 Month Momentum % | 20.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | |||||
| Quick Ratio | 5.1 | |||||
| Cash Ratio | 4.82 | |||||
| Days Sales Outstanding | 2059.94 | |||||
| Days Payable | 30349.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.2 | |||||
| Shareholder Yield % | -19.56 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -100 | |||||
| Operating Margin % | -141465.52 | |||||
| Net Margin % | -138608.62 | |||||
| FCF Margin % | -58908.33 | |||||
| ROE % | -14841.78 | |||||
| ROA % | -115.96 | |||||
| ROIC % | -8237.16 | |||||
| ROC (Joel Greenblatt) % | -75995.02 | |||||
| ROCE % | -125.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.75 | |||||
| EV-to-EBITDA | -0.75 | |||||
| EV-to-Revenue | 961.78 | |||||
| EV-to-Forward-Revenue | 8.91 | |||||
| EV-to-FCF | -1.61 | |||||
| Earnings Yield (Greenblatt) % | -133.33 | |||||
| FCF Yield % | -25.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Opthea Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.108 | ||
| EPS (TTM) (€) | -0.277 | ||
| Beta | 1.99 | ||
| Volatility % | 105.34 | ||
| 14-Day RSI | 42.51 | ||
| 14-Day ATR (€) | 0.012531 | ||
| 20-Day SMA (€) | 0.377 | ||
| 12-1 Month Momentum % | 20.86 | ||
| 52-Week Range (€) | 0.158 - 0.476 | ||
| Shares Outstanding (Mil) | 662.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Opthea Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Opthea Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Opthea Ltd Frequently Asked Questions
What is Opthea Ltd(FRA:UKJ)'s stock price today?
The current price of FRA:UKJ is €0.35. The 52 week high of FRA:UKJ is €0.48 and 52 week low is €0.16.
When is next earnings date of Opthea Ltd(FRA:UKJ)?
The next earnings date of Opthea Ltd(FRA:UKJ) is 2024-08-30 Est..
Does Opthea Ltd(FRA:UKJ) pay dividends? If so, how much?
Opthea Ltd(FRA:UKJ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers